Thus, this study supported the hypothesis that bNAbs given early in infection before natural antibodies arise may form immune complexes, which, once cross-presented to CD8+ T cells, may boost antiviral immune responses30 and ultimately lead to viral control. This evidence concerns the gene CD8A and infection.